Table 1.
Baseline demographic and clinical characteristics
| All patients (n = 2579) | |
|---|---|
| Demographics | |
| Age (mean [SD]) | 61.7 (14.5) |
| Male gender, n (%) | 1541 (59.8) |
| Race/ethnicity (%) | |
| Black, n(%) | 884 (34.3) |
| Hispanic, n (%) | 876 (34.0) |
| White, n (%) | 819 (31.8) |
| Medical history | |
| History of stroke, n (%) | 551 (21.4) |
| Hypertension, n (%) | 2074 (81.7) |
| Diabetes, n (%) | 727 (28.7) |
| Alcohol use, n (%) | 974 (37.8) |
| Medication | |
| Warfarin use (%) | 219 (8.5) |
| Antiplatelet use (%) | 701 (27.2) |
| Admission variables | |
| SBP (mean [SD]) | 184.8 (38.0) |
| BMI (median [IQR]) | 27.7 [24.1–32.6] |
| Admission GCS (median [IQR]) | 15.0 [11.0–15.0] |
| Admission glucose (mean [SD]) | 148.6 (64.6) |
| Time from ictus to baseline CT (%) | |
| < 6 h, n (%) | 1355 (52.5) |
| > 6 h, n (%) | 1094 (42.4) |
| Unknown, n (%) | 130 (5.0) |
| Hemorrhage characteristics | |
| Non-lobar hemorrhage location, n (%) | 1805 (70.0) |
| ICH volume in mL (median [IQR]) | 10.5 [4.0–25.3] |
| IVH presence, n (%) | 1018 (39.4) |
| Graeb score, n (%) | |
| None (0) | 1548 (60.0) |
| Some IVH (Graeb score 1–3) | 423 (16.4) |
| Modest IVH (Graeb score 4–6) | 371 (14.4) |
| Severe IVH (Graeb score > 7) | 229 (8.9) |
| Undetermined | 8 (0.3) |
| CSVD variables | |
| Leukoaraiosis, n (%) | |
| Grade 0 | 1065 (41.3) |
| Grade 1 | 447 (17.3) |
| Grade 2 | 447 (17.3) |
| Grade 3 | 265 (10.3) |
| Grade 4 | 329 (12.8) |
| Undetermined | 26 (1.0) |
| Global atrophy, n (%) | |
| Grade 0 | 834 (32.3) |
| Grade 1 | 356 (13.8) |
| Grade 2 | 722 (41.8) |
| Grade 3 | 295 (11.4) |
| Grade 4 | 318 (12.3) |
| Undetermined | 54 (2.1) |
BMI body mass index; CSVD cerebral small vessel disease, CT computed tomography, GCS Glasgow Coma Score, ICH intracerebral hemorrhage, IVH intraventricular hemorrhage, IQR interquartile range, SBP systolic blood pressure, SD standard deviation